A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

• DOI: 10.1126/scitranslmed.abc3103
• Publication Date: 2020-08-17T23:10:43Z
• Authors: Ludivine Grzelak; Sarah Temmam; Cyril Planchais; Caroline Demeret; Laura Tondeur; Christèle Huon; Florence Guivel-B...; Isabelle Staropoli; Maxime Chazal; Jeremy Dufloo; Delphine Planas; Julian Buchrieser; Maaran Michael Rajah; Remy Robinot; Françoise Porrot; Mélanie Albert; Kuang-Yu Chen; Bernadette Cresce...; Flora Donati; François Anna; Philippe Souque; Marion Gransagne; Jacques Bellalou; Mireille Nowakowski; Marija Backovic; Lila Bouadma; Lucie Le Fevre; Quentin Le Hingrat; Diane Descamps; Annabelle Pourbaix; Cédric Laouénan; Jade Ghosn; Yazdan Yazdanpanah; Camille Besombes; Nathalie Jolly; Sandrine Pellerin...; Olivia Cheny; Marie-Noëlle Unge...; Guillaume Mellon; Pascal Morel; Simon Rolland; Felix A. Rey; Sylvie Behillil; Vincent Enouf; Audrey Lemaitre; Marie-Aude Créach; Stephane Petres; Nicolas Escriou; Pierre Charneau; Arnaud Fontanet; Bruno Hoen; Timothée Bruel; Marc Eloit; Hugo Mouquet; Olivier Schwartz; Sylvie van der Werf
• Keywords: Sars virus; 2019-20 coronavirus outbreak

Different serological assays measuring anti–SARS-CoV-2 antibodies and their neutralizing activity in samples from individuals with severe mild COVID-19 are compared.